Skip to main content
Log in

Pharmacokinetic studies on the selectiveβ 1-receptor antagonist metoprolol in man

  • Published:
Journal of Pharmacokinetics and Biopharmaceutics Aims and scope Submit manuscript

Abstract

The pharmacokinetics of 3H-metoprolol, a new selective β 1-receptor antagonist, have been studied in healthy volunteers by following the plasma concentrations and the urinary excretion of the unchanged compound and its total radioactive metabolites after oral and intravenous administration. The compound was rapidly and completely absorbed after oral administration, and about 40% of the dose reached the systemic circulation. The estimated half-life of the absorption process was 10 min. Metoprolol was extensively distributed to extravascular tissues, with the half-life of the distribution phase close to 12 min. About 95% of the dose was excreted in the urine within 72 hr, mainly in metabolized form. The elimination halflife of the compound was close to 3 hr as was also the half-life of the total metabolites after oral administration. After intravenous administration, the elimination half-life of the metabolites was raised to 5 hr, indicating that the route of administra tion might influence the metabolic pathways of the parent compound.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. B. Åblad, E. Carlsson, and L. Ek. Pharmacologic studies of two new cardioselective adrenergic beta-receptor antagonists.Life Sci. 12: 107–119 (1973).

    Article  Google Scholar 

  2. M. Rowland. Influence of route of administration on drug availability.J. Pharm. Sci. 61: 70–74 (1972).

    Article  CAS  PubMed  Google Scholar 

  3. P. J. Davies and P. Rabinowitz.Numerical Integration, Blaisdell, Waltham, Mass., 1967, p. 22.

    Google Scholar 

  4. J. G. Wagner.Biopharmaceutics and Relevant Pharmacokinetics, Drug Intelligence Publications, Hamilton, Ill., 1971, p. 298.

    Google Scholar 

  5. N. R. Glass. A technique for fitting nonlinear models to biological data.Ecology 48: 1010–1012 (1967).

    Article  Google Scholar 

  6. D. S. Riggs.The Mathematical Approach to Physiological Problems, M.I.T. Press, Cambridge, Mass., 1970, p. 208.

    Google Scholar 

  7. J. C. K. Loo and S. Riegelman. Assessment of pharmacokinetic constants from postinfusion blood curves obtained after i.v. infusion.J. Pharm. Sci. 59: 53–55 (1970).

    Article  CAS  PubMed  Google Scholar 

  8. M. Gibaldi, R. Nagashima, and G. Levy. Relationship between drug concentration in plasma or serum and amount of drug in the body.J. Pharm. Sci. 58: 193–197 (1969).

    Article  CAS  Google Scholar 

  9. J. G. Wagner and E. Nelson. Per cent absorbed time plots derived from blood level and/or urinary excretion data.J. Pharm. Sci. 52: 610–611 (1963).

    Article  CAS  PubMed  Google Scholar 

  10. J. C. K. Loo and S. Riegelman. New method for calculating the intrinsic absorption rate of drugs.J. Pharm. Sci. 57: 918–928 (1968).

    Article  CAS  PubMed  Google Scholar 

  11. D. Perrier, M. Gibaldi, and R. N. Boyes. Prediction of systemic availability from plasmalevel data after oral drug administration.J. Pharm. Pharmacol. 25: 256–257 (1973).

    Article  CAS  PubMed  Google Scholar 

  12. D. G. Shand and R. E. Rangno. The disposition of propranolol. I. Elimination during absorption in man.Pharmacology 7: 159–168 (1972).

    Article  CAS  PubMed  Google Scholar 

  13. M. Gibaldi, R. N. Boyes, and S. Feldman. Influence of first-pass effect on availability of drugs on oral administration.J. Pharm. Sci. 60: 1338–1340 (1971).

    Article  CAS  PubMed  Google Scholar 

  14. S. E. Bradely. InHandbook of Physiology, Sect. II, Vol. II, Williams and Wilkins, Baltimore, 1963, p. 1387.

    Google Scholar 

  15. T. Chulski, R. H. Johnsson, C. A. Schlagel, and J. G. Wagner. Direct proportionality of urinary excretion rate and serum level of tetracycline in human subjects.Nature (Lond.) 198: 450–453 (1963).

    Article  CAS  Google Scholar 

  16. J. G. Wagner. Pharmacokinetics: Notes supplied by John G. Wagner, Ph.D., J. M. Richards Laboratory, Grosse Point Park, Mich., 1969, p. 93.

    Google Scholar 

  17. J. G. Wagner.Biopharmaceutics and Relevant Pharmacokinetics, Drug Intelligence Publications, Hamilton, Ill., 1971, p. 261.

    Google Scholar 

  18. S. A. Kaplan, M. Lewis, M. A. Schwartz, E. Postma, S. Cotler, C. W. Abruzzo, T. L. Lee, and R. E. Weinfeld. Pharmacokinetic model for chlordiazepoxide-HCl in the dog.J. Pharm. Sci. 59: 1569–1574 (1970).

    Article  CAS  PubMed  Google Scholar 

  19. W. J. O'Reilly. Pharmacokinetics in drug metabolism and toxicology.Canad. J. Pharm. Sci. 7: 66–77 (1972).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Regårdh, C.G., Borg, K.O., Johansson, R. et al. Pharmacokinetic studies on the selectiveβ 1-receptor antagonist metoprolol in man. Journal of Pharmacokinetics and Biopharmaceutics 2, 347–364 (1974). https://doi.org/10.1007/BF01061407

Download citation

  • Received:

  • Revised:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01061407

Key words

Navigation